MYRIAD GENETICS INC — Director's Dealing 2015

Nov 5, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2015-11-04

Reporting Person: MARSH RICHARD M (E.V.P., General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-10-21	Common Stock	G	2628.0	$0.0	Disposed	70123	Direct
2015-11-04	Common Stock	G	1739.0	$0.0	Disposed	68384	Direct
2015-11-04	Common Stock	M	35000.0	$22.93	Acquired	103384	Direct
2015-11-04	Common Stock	S	35000.0	$44.5	Disposed	68384	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-11-04	Non-Qualified Stock Option (right to buy)	$22.93	M	35000.0	Disposed	2018-09-10	Common Stock (35000)	Direct

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.